Increased rate of FEV1 decline in HIV patients despite effective treatment with HAART.
Gloria SampérizFrancisco FanjulJose Luis ValeraMeritxell LopezÁngel RiosMaría PeñarandaAntoni CampinsMelchor RieraAlvar AgustiPublished in: PloS one (2019)
Despite adequate immune-viral control by HAART, lung function decline remains increased in most HIV patients, even in non-smokers and quitters. Alcohol abuse is a preventable risk factor to decrease the accelerated FEV1 decline in this population.
Keyphrases
- end stage renal disease
- lung function
- newly diagnosed
- ejection fraction
- chronic kidney disease
- antiretroviral therapy
- hepatitis c virus
- human immunodeficiency virus
- hiv positive
- prognostic factors
- chronic obstructive pulmonary disease
- risk factors
- hiv testing
- hiv infected patients
- patient reported outcomes
- alcohol consumption